Fig. 6: Study flowchart. ctDNA, circulating tumour DNA.
AEs adverse events, HER2 human epidermal growth factor receptor 2.
Fig. 6: Study flowchart. ctDNA, circulating tumour DNA. | npj Breast Cancer
AEs adverse events, HER2 human epidermal growth factor receptor 2.
